Literature DB >> 17977964

Varicella-zoster virus glycoprotein M homolog is glycosylated, is expressed on the viral envelope, and functions in virus cell-to-cell spread.

Yoshiaki Yamagishi1, Tomohiko Sadaoka, Hironori Yoshii, Pranee Somboonthum, Takayoshi Imazawa, Kazuhiro Nagaike, Keiichi Ozono, Koichi Yamanishi, Yasuko Mori.   

Abstract

Although envelope glycoprotein M (gM) is highly conserved among herpesviruses, the varicella-zoster virus (VZV) gM homolog has never been investigated. Here we characterized the VZV gM homolog and analyzed its function in VZV-infected cells. The VZV gM homolog was expressed on virions as a glycoprotein modified with a complex N-linked oligosaccharide and localized mainly to the Golgi apparatus and the trans-Golgi network in infected cells. To analyze its function, a gM deletion mutant was generated using the bacterial artificial chromosome system in Escherichia coli, and the virus was reconstituted in MRC-5 cells. VZV is highly cell associated, and infection proceeds mostly by cell-to-cell spread. Compared with wild-type VZV, the gM deletion mutant showed a 90% reduction in plaque size and 50% of the cell-to-cell spread in MRC-5 cells. The analysis of infected cells by electron microscopy revealed numerous aberrant vacuoles containing electron-dense materials in cells infected with the deletion mutant virus but not in those infected with wild-type virus. However, enveloped immature particles termed L particles were found at the same level on the surfaces of cells infected with either type of virus, indicating that envelopment without a capsid might not be impaired. These results showed that VZV gM is important for efficient cell-to-cell virus spread in cell culture, although it is not essential for virus growth.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17977964      PMCID: PMC2224567          DOI: 10.1128/JVI.01722-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells.

Authors:  K R Thomas; M R Capecchi
Journal:  Cell       Date:  1987-11-06       Impact factor: 41.582

2.  The open reading frames UL3, UL4, UL10, and UL16 are dispensable for the replication of herpes simplex virus 1 in cell culture.

Authors:  J D Baines; B Roizman
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

Review 3.  Herpesvirus entry: an update.

Authors:  Patricia G Spear; Richard Longnecker
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

4.  Identification and characterization of a human cytomegalovirus gene coding for a membrane protein that is conserved among human herpesviruses.

Authors:  R Lehner; H Meyer; M Mach
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

5.  Structural analysis of the varicella-zoster virus gp98-gp62 complex: posttranslational addition of N-linked and O-linked oligosaccharide moieties.

Authors:  E A Montalvo; R T Parmley; C Grose
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

6.  Identification and structure of the gene encoding gpII, a major glycoprotein of varicella-zoster virus.

Authors:  P M Keller; A J Davison; R S Lowe; C D Bennett; R W Ellis
Journal:  Virology       Date:  1986-07-15       Impact factor: 3.616

7.  Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome.

Authors:  Susan M Varnum; Daniel N Streblow; Matthew E Monroe; Patricia Smith; Kenneth J Auberry; Ljiljana Pasa-Tolic; Dai Wang; David G Camp; Karin Rodland; Steven Wiley; William Britt; Thomas Shenk; Richard D Smith; Jay A Nelson
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

8.  Cloning of the varicella-zoster virus genome as an infectious bacterial artificial chromosome in Escherichia coli.

Authors:  Kazuhiro Nagaike; Yasuko Mori; Yasuyuki Gomi; Hironori Yoshii; Michiaki Takahashi; Markus Wagner; Ulrich Koszinowski; Koichi Yamanishi
Journal:  Vaccine       Date:  2004-09-28       Impact factor: 3.641

9.  Location and orientation of homologous sequences in the genomes of five herpesviruses.

Authors:  A J Davison; N M Wilkie
Journal:  J Gen Virol       Date:  1983-09       Impact factor: 3.891

10.  The requirement of varicella zoster virus glycoprotein E (gE) for viral replication and effects of glycoprotein I on gE in melanoma cells.

Authors:  Chengjun Mo; Jay Lee; Marvin Sommer; Charles Grose; Ann M Arvin
Journal:  Virology       Date:  2002-12-20       Impact factor: 3.616

View more
  18 in total

1.  The C-terminus of varicella-zoster virus glycoprotein M contains trafficking motifs that mediate skin virulence in the SCID-human model of VZV pathogenesis.

Authors:  Leigh Zerboni; Phillip Sung; Marvin Sommer; Ann Arvin
Journal:  Virology       Date:  2018-08-14       Impact factor: 3.616

2.  Varicella-zoster virus ORF49 functions in the efficient production of progeny virus through its interaction with essential tegument protein ORF44.

Authors:  Tomohiko Sadaoka; Satoshi Serada; Junko Kato; Mayuko Hayashi; Yasuyuki Gomi; Tetsuji Naka; Koichi Yamanishi; Yasuko Mori
Journal:  J Virol       Date:  2013-10-23       Impact factor: 5.103

3.  The insulin degrading enzyme binding domain of varicella-zoster virus (VZV) glycoprotein E is important for cell-to-cell spread and VZV infectivity, while a glycoprotein I binding domain is essential for infection.

Authors:  Mir A Ali; Qingxue Li; Elizabeth R Fischer; Jeffrey I Cohen
Journal:  Virology       Date:  2009-02-23       Impact factor: 3.616

4.  Myelin-associated glycoprotein mediates membrane fusion and entry of neurotropic herpesviruses.

Authors:  Tadahiro Suenaga; Takeshi Satoh; Pranee Somboonthum; Yasushi Kawaguchi; Yasuko Mori; Hisashi Arase
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

5.  Red-mediated transposition and final release of the mini-F vector of a cloned infectious herpesvirus genome.

Authors:  Felix Wussow; Helmut Fickenscher; B Karsten Tischer
Journal:  PLoS One       Date:  2009-12-04       Impact factor: 3.240

6.  Genome-wide mutagenesis reveals that ORF7 is a novel VZV skin-tropic factor.

Authors:  Zhen Zhang; Anca Selariu; Charles Warden; Grace Huang; Ying Huang; Oluleke Zaccheus; Tong Cheng; Ningshao Xia; Hua Zhu
Journal:  PLoS Pathog       Date:  2010-07-01       Impact factor: 6.823

7.  Complete DNA sequences of two oka strain varicella-zoster virus genomes.

Authors:  Sueli L Tillieux; Wendy S Halsey; Elizabeth S Thomas; John J Voycik; Ganesh M Sathe; Ventzislav Vassilev
Journal:  J Virol       Date:  2008-09-10       Impact factor: 5.103

8.  Epstein-Barr virus glycoprotein gM can interact with the cellular protein p32 and knockdown of p32 impairs virus.

Authors:  Harish Changotra; Susan M Turk; Antonio Artigues; Nagendra Thakur; Mindy Gore; Martin I Muggeridge; Lindsey M Hutt-Fletcher
Journal:  Virology       Date:  2016-01-13       Impact factor: 3.616

9.  The attenuated genotype of varicella-zoster virus includes an ORF0 transitional stop codon mutation.

Authors:  Geoffrey A Peters; Shaun D Tyler; John E Carpenter; Wallen Jackson; Yasuko Mori; Ann M Arvin; Charles Grose
Journal:  J Virol       Date:  2012-07-25       Impact factor: 5.103

10.  Quantitative measurement of varicella-zoster virus infection by semiautomated flow cytometry.

Authors:  Irina V Gates; Yuhua Zhang; Cindy Shambaugh; Meredith A Bauman; Charles Tan; Jean-Luc Bodmer
Journal:  Appl Environ Microbiol       Date:  2009-02-05       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.